Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV000788601 | SCV000927768 | likely pathogenic | not provided | 2018-06-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001220463 | SCV001392452 | pathogenic | Autosomal recessive polycystic kidney disease | 2019-05-22 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gln1444*) in the PKHD1 gene. It is expected to result in an absent or disrupted protein product. This variant has been observed in an individual affected with polycystic kidney disease (PMID: 16133180). For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in PKHD1 are known to be pathogenic (PMID: 19940839). |
Gene |
RCV000788601 | SCV003936652 | pathogenic | not provided | 2022-12-29 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 16133180) |